Story
S&P Global Upgrades HealthEquity to 'BB+' on Strong Earnings and Favorable Rate Environment

S&P Global Ratings has upgraded HealthEquity Inc. (NASDAQ:HQY), a leading administrator of health savings accounts (HSAs), reflecting the company's strong financial performance and favorable market conditions. The ratings agency raised its issuer credit rating on the company to 'BB+' from 'BB', pointing to an expanding EBITDA base driven by consistent growth and the current high-interest-rate environment.
Details of the Rating Action
In its announcement, S&P Global detailed several adjustments to HealthEquity's ratings. Beyond the main issuer credit upgrade, the agency also took the following actions:
- Raised the issue-level rating on HealthEquity's senior unsecured notes to 'BB-' from 'B+'.
- Affirmed the 'BBB-' rating on the company's revolving credit facility.
The upgrades are underpinned by S&P's expectation that HealthEquity's leverage will remain below 2x. The firm's analysis highlighted the increasing importance of HSAs as a tool for managing healthcare expenses, noting that costs per employee rose 9% in 2026.
Financial Outlook and Market Position
AdHealthEquity is well-positioned to capitalize on the current economic climate. The company benefits directly from elevated interest rates, with S&P noting that the average annualized yield on its HSA cash is expected to be in the high-3% range. Furthermore, HealthEquity has used hedging activities to lock in rates near 5% on new funds.
The ratings agency projects robust financial performance, forecasting top-line growth of 8% in fiscal 2027 and an expansion of adjusted margins by approximately 250 basis points to 41.5%. This growth is supported by strong client retention, with two-thirds of new HSAs originating from existing customers. S&P also anticipates HealthEquity's adjusted leverage will decline to 1.2x by 2027.
Strategic Initiatives and Capital Allocation
HealthEquity continues to enhance its operational efficiency by adopting AI and digital tools, which has helped decrease service costs per account. The company is also expanding its platform to cover new wellness categories, including skin care, sleep, and vision, though it faces significant competition in the marketplace.
With a solid liquidity position, including $256 million in cash and availability under its $1 billion revolving credit facility, HealthEquity plans to direct the majority of its excess cash flow toward share repurchases and other shareholder distributions, according to the S&P report.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.